Sector Alpha Week of 2026-09-17
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-17

State Street Corporation

STT
Financials · Asset Management

State Street Corporation's price has outrun its earnings. +61.1% in a year against EPS +14.5% — the market is paying now for delivery later.

The sharpest disagreement: the price moved +61.1% in a year while annual EPS moved +14.5% — the difference is re-rating, and re-rating has to be repaid with earnings.

The price is in a confirmed uptrend (72 weeks in) while the P/BV sits at the 100th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +56.5% year on year, with the the net margin at 26.7%. What settles it: whether earnings grow into a price that has already moved.

Stage
Mixed
fundamental trajectory, 12 quarters
Price
$183
+61.1% 1Y
P/BV
2.0×
100th pctile
of its own 5-year range
Revenue (Jun 26)
$4.0 B
+17.4% YoY
Profit (Jun 26)
$1.1 B
+56.5% YoY
Net margin
26.7%
+6.7 pp YoY
ROE
12%
FY25
ROA
0.87%
latest
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

State Street Corporation trades at $183, in a confirmed uptrend and 72 weeks into that stage. That is +20.7% against its own 200-day average. It sits at 86% of a 52-week range of $111 to $194. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 26 straight weeks.

Today the stock is in a confirmed uptrend — week 72 of stage 2. At $183 it trades +20.7% versus its 200-day average and sits at 86% of its 52-week range ($111–$194).

Sep 26: $183 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+20.7% versus the 200-day line, week 72 of stage 2
Price50-day avg200-day avg
S3S2S2$205$167$129$90.5$52.4$$183$152Sep 23Jun 24Mar 25Dec 25Sep 26
S3S2S2$205$167$129$90.5$52.4$$183$152Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (533 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +244% while the S&P 500 moved +255% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 26 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.

State Street Corporation trades at 2.0× P/BV, about the priciest it has ever traded. Its long-run median P/BV is 1.1×, measured across 5.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/BV of 2.0× is about the priciest it has ever traded, against a long-run median of 1.1× measured over 5.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

The honest context for that discount: a bank earning about 12% on its equity is worth less per dollar of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.

P/BV 2.0× vs a 1.1× long-run median P/BV, weekly (left axis); book value per share, quarterly steps drawn weekly (right axis). 5.2-year window; brief peaks above 1.9× shown pinned at the top. The book value / share bars are red where the reading is lower than the quarter before.
about the priciest it has ever traded
P/BVMedianBook value / share (quarterly)
2.0×$1071.7×$80.01.4×$53.31.1×$26.70.8×$0.0×$1.85×$99Jul 21Oct 22Feb 24May 25Sep 26
2.0×$1071.7×$80.01.4×$53.31.1×$26.70.8×$0.0×$1.85×$99Jul 21Feb 24Sep 26
PEG 0.88 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
2.7×2.2×1.7×1.1×0.6××0.88×Sep 21Sep 22Dec 23Mar 25Jun 26
2.7×2.2×1.7×1.1×0.6××0.88×Sep 21Dec 23Jun 26
P/BV
2.0×
100th percentile of 5y
PEG
0.71
as reported

🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +61.1% — the price ran ahead of the book, pushing the multiple up its own range.

The price move, decomposed: over 5y, of the +16.6%/yr price move, ~+6.7%/yr came from book-value growth and ~+9.9 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the book-value line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

State Street Corporation reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +54.6% at its peak to +21.5% but is still expanding, ROE holding at 12.4%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +7.2% in FY25, profit +9.3% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
9.6%53%6.6%31%3.6%8.5%0.6%−14%−2.4%−36%%%7.2%9.3%FY21FY23FY25
9.6%53%6.6%31%3.6%8.5%0.6%−14%−2.4%−36%%%7.2%9.3%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit rolling over
RevenueProfitEPS
14%76%9.4%46%5.2%17%0.9%−13%−3.3%−42%%%12.4%21.5%27%Sep 23Dec 24Jun 26
14%76%9.4%46%5.2%17%0.9%−13%−3.3%−42%%%12.4%21.5%27%Sep 23Dec 24Jun 26
ROE Trailing-twelve-month net profit as a share of quarter-end equity, %.
the return curve, computed quarterly
ROE
13%11%9.8%8.4%6.9%%12.4%Sep 23Mar 24Dec 24Sep 25Jun 26
13%11%9.8%8.4%6.9%%12.4%Sep 23Dec 24Jun 26
Revenue growth
Steady high
latest +12.4% · span −2.1% to +12.4%
Profit growth
Rolling over
latest +21.5% · span −34.1% to +57.8%
EPS growth
Rolling over
latest +27.0% · span −28.1% to +67.9%
ROE
Steady high
latest 12.4% · span 7.3%–12.4%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+7.2%+4.7%
Profit+9.3%+2.0%
EPS+14.5%+9.3%
Stock price+61.1%+36.5%+16.6%+10.2%
Revenue YoY (Jun 26)
+17.4%
latest quarter vs a year ago
Profit YoY (Jun 26)
+56.5%
latest quarter vs a year ago
Revenue 10y
3.8%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

49.7/100 — rank 14 of 29 in Asset Management · 80% evidence confidence

State Street Corporation scores 49.7 out of 100 against the 29 companies it is compared with in Asset Management, ranking 14. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 19.3 + 8.9 + 6.9 + 14.6 = 49.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.

05 · Revenue

Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.

State Street Corporation reported $4.0 B of income in the Jun 26 quarter, +17.4% year on year. That is the 10th straight quarter of year-on-year growth. Over 4 years it has compounded at 3.8% a year. The last full year, FY25, came in at $13.9 B. The last four reported quarters add to $15.1 B.

FY25 revenue came in at $13.9 B (+7.2% on the year), capping 4 years at 3.8% compound. The latest quarter (Jun 26) printed $4.0 B, +17.4% year on year — the 10th consecutive quarter of year-over-year growth.

FY25 revenue $13.9 B (+7.2% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
3.8% a year over 4 years
RevenueYoY growth
159.6%116.6%7.53.6%3.80.6%0.0−2.4%$ B%$14B7.2%FY21FY23FY25
159.6%116.6%7.53.6%3.80.6%0.0−2.4%$ B%$14B7.2%FY21FY23FY25
Jun 26: $4.0 B (+17.4% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
10th straight quarter of growth
Revenue (quarterly)YoY growth
4.424%3.315%2.26.1%1.1−2.7%0.0−12%$ B%$4B17.4%Sep 23Dec 24Jun 26
4.424%3.315%2.26.1%1.1−2.7%0.0−12%$ B%$4B17.4%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +12.4% growth against the decade's 3.8% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +12.4% over the last 4 quarters against +11.7%/yr over the last 8 — stabilising; TTM profit +21.5% vs +38.4%/yr — rolling over.

06 · Net margin

Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.

State Street Corporation's net margin is 26.7% in the Jun 26 quarter, +6.7 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 16.2% to 22.8%. The current quarter is running above every full year in that window.

The latest quarter's net margin is 26.7%, +6.7 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 16.2%–22.8%.

Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.

FY25: 21.1% Net margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a 16.2–22.8% band over 5 years
net marginYoY change (pp)
23%5.4%21%2.2%20%−1.0%18%−4.3%16%−7.5%%%21.1%0.4%FY21FY23FY25
23%5.4%21%2.2%20%−1.0%18%−4.3%16%−7.5%%%21.1%0.4%FY21FY23FY25
Jun 26: 26.7% net margin (+6.7 pp YoY) Quarterly net margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Net profit as a share of total revenue, per quarter.
Net marginYoY change (pp)
28%19%23%9.2%17%0.0%11%−9.5%5.3%−19%%%26.7%6.7%Sep 23Dec 24Jun 26
28%19%23%9.2%17%0.0%11%−9.5%5.3%−19%%%26.7%6.7%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

State Street Corporation earned $1.1 B of net profit in the Jun 26 quarter, +56.5% year on year. It is the 2nd consecutive quarter of growth. Full-year FY25 profit was $2.9 B. The 4-year compound rate is 2.2%. That is 26.7% of the quarter's revenue. The same quarter a year earlier earned $0.7 B.

Jun 26 profit was $1.1 B, +56.5% year on year — the 2nd consecutive quarter of growth. On the full year, FY25 printed $2.9 B (+9.3%), and the 4-year compound rate is 2.2%.

FY25 profit $2.9 B (+9.3% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
2.2% a year over 4 years
Net profitYoY growth
3.244%2.424%1.64.4%0.8−16%0.0−35%$ B%$3B9.3%FY21FY23FY25
3.244%2.424%1.64.4%0.8−16%0.0−35%$ B%$3B9.3%FY21FY23FY25
Jun 26: $1.1 B (+56.5% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
2nd straight quarter of growth
Net profit (quarterly)YoY growth
1.2299%0.9199%0.6100%0.30.0%0.0−99%$ B%$1B56.5%Sep 23Dec 24Jun 26
1.2299%0.9199%0.6100%0.30.0%0.0−99%$ B%$1B56.5%Sep 23Dec 24Jun 26

Why profit moved: revenue contributed +17.4% and the margin +6.7 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.

Pace comparison, last four quarters: profit +22.3% vs revenue +12.4%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.

08 · Asset quality — the ladder

Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.

Loan-book quality history is not available for State Street Corporation, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.

We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.

Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.

09 · The loan book

The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.

State Street Corporation's revenue grew +7.2% in FY25 to $13.9 B, so the book is growing. The latest quarter ran +17.4% year on year. The net margin on that income is 26.7%, +6.7 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.

FY25 revenue was $13.9 B, +7.2% on the year, and the latest quarter ran +17.4% year on year. The net margin on that revenue is 26.7% this quarter (+6.7 pp YoY) — growth with a widening margin on it.

FY25: revenue $13.9 B (+7.2% YoY) with the net margin at 21.1% Revenue by fiscal year, $ B (bars, left); net margin, % (line, right). 5-year window. A bar is red when it is lower than the year before.
RevenueNet margin
1523%1121%7.520%3.818%0.016%$ B%$14B21.1%FY21FY22FY23FY24FY25
1523%1121%7.520%3.818%0.016%$ B%$14B21.1%FY21FY23FY25

The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.

10 · Returns on equity and assets

Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.

State Street Corporation earns a return on equity of 11% in FY25. Its trough over the ladder below was 8% in FY23. On the asset side every $100 of the balance sheet earned about $0.87, which is the return before leverage is applied.

FY25 ROE came in at 11%, recovered from a FY23 trough of 8%. On assets, the latest reading is about 0.87% — every $100 the bank deploys earns roughly $0.87 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.

FY25: ROE 11%, ROA 0.80% Return on equity by fiscal year, % (line, left); return on assets, % (line, right). 5-year window. A lender is judged on ROE and ROA — return on invested capital does not apply to a bank.
up from a FY23 trough of 8%
ROEROA
11%0.92%10%0.84%9.6%0.75%8.8%0.66%8.0%0.58%%%10.8%0.8%FY21FY23FY25
11%0.92%10%0.84%9.6%0.75%8.8%0.66%8.0%0.58%%%10.8%0.8%FY21FY23FY25
Jun 26: ROE 12.8% (TTM), ROA 0.90% Trailing-twelve-month return on equity (left) and on assets (right), per quarter, %. Last 12 quarters, anchored to the annual figure.
ROE (TTM)ROA (TTM)
13%0.9%12%0.8%10%0.7%8.5%0.6%7.0%0.5%%%12.8%0.9%Sep 23Dec 24Jun 26
13%0.9%12%0.8%10%0.7%8.5%0.6%7.0%0.5%%%12.8%0.9%Sep 23Dec 24Jun 26

Why ROE moved: profit compounded 2.2% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.

11 · Dividend

Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.

State Street Corporation paid $3.36 per share over the last four reported quarters. The most recent declaration was $0.84 for Jun 26. Against the current price of $183 that is a trailing yield of 1.84%, measured on dividends already paid rather than on a forecast.

State Street Corporation paid $3.36 per share across the last four reported quarters, most recently $0.84 for Jun 26. Against the current price of $183 the trailing twelve months work out to 1.84% — trailing dividends measured against today's price, not a forward estimate.

Dividend per share by quarter Declared dividend per share, $ B, per reported quarter. 12 quarters on file.
latest $0.84 (Jun 26)
Dividend per share
0.90.70.50.20.0$ B$1BSep 23Mar 24Dec 24Sep 25Jun 26
0.90.70.50.20.0$ B$1BSep 23Dec 24Jun 26
12 · Debt

Debt

For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.

A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.

13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

0.0% of State Street Corporation's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 0.0 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 0.0% of the float is sold short, and at typical trading volumes it would take about 0.0 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
0.0%
of the tradable float
Days to cover
0.0
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

State Street Corporation: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.

The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.

15 · Related companies · Asset Management
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Victory Capital Holdings, Inc.VCTR 67.4/100Favorable setup76% evidence LEADER 25.0/35 Income 64.1% · PAT 29.1% 71% evidence 16.1/25 ROA 3.6% · ROE 6.4% · GNPA — 68% evidence 7.6/20 P/BV 2.29× · P/BV÷ROE 0.36 70% evidence 18.7/20 RS sector 22.7% · RS bench 24.4% · 1Y 54.7%12 of 12 weeks ahead 100% evidence
Exact sum: 25 + 16.1 + 7.6 + 18.7 = 67.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Principal Financial Group, Inc.PFG 62.3/100Mixed-positive evidence80% evidence LEADER 22.5/35 Income 3.7% · PAT 36.9% 81% evidence 11.2/25 ROA 0.4% · ROE 13.3% · GNPA — 68% evidence 14.1/20 P/BV 1.81× · P/BV÷ROE 0.14 70% evidence 14.5/20 RS sector 11.4% · RS bench 13.1% · 1Y 42.7%10 of 12 weeks ahead 100% evidence
Exact sum: 22.5 + 11.2 + 14.1 + 14.5 = 62.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3SEI Investments CompanySEIC 59.2/100Mixed-positive evidence60% evidence LEADER 18.0/35 Income — · PAT — 26% evidence 17.0/25 ROA 5.2% · ROE 7.7% · GNPA — 68% evidence 6.0/20 P/BV 4.21× · P/BV÷ROE 0.55 70% evidence 18.2/20 RS sector 9.7% · RS bench 11.2% · 1Y 20.6%12 of 12 weeks ahead 100% evidence
Exact sum: 18 + 17 + 6 + 18.2 = 59.2 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
4Ameriprise Financial, Inc.AMP 57.0/100Mixed-positive evidence64% evidence BREAKING OUT 18.3/35 Income 10.6% · PAT 22.4% 62% evidence 16.4/25 ROA — · ROE 17.9% · GNPA — 34% evidence 7.3/20 P/BV 6.37× · P/BV÷ROE 0.36 70% evidence 15.0/20 RS sector 2.6% · RS bench 3.9% · 1Y 10.5%10 of 12 weeks ahead 100% evidence
Exact sum: 18.3 + 16.4 + 7.3 + 15 = 57 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5T. Rowe Price Group, Inc.TROW 55.6/100Mixed-positive evidence80% evidence ASLEEP 16.0/35 Income 7% · PAT 9.1% 81% evidence 20.1/25 ROA 12% · ROE 16.2% · GNPA — 68% evidence 14.7/20 P/BV 2× · P/BV÷ROE 0.12 70% evidence 4.8/20 RS sector -8.6% · RS bench -7.3% · 1Y -3.4%5 of 12 weeks ahead 100% evidence
Exact sum: 16 + 20.1 + 14.7 + 4.8 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Brookfield Asset Management Ltd.BAM 54.8/100Mixed-positive evidence80% evidence ASLEEP 28.5/35 Income 31.9% · PAT 32.8% 81% evidence 17.9/25 ROA 5.6% · ROE 10.2% · GNPA — 68% evidence 4.4/20 P/BV 9.53× · P/BV÷ROE 0.94 70% evidence 4.0/20 RS sector -16.5% · RS bench -15.4% · 1Y -24.7%4 of 12 weeks ahead 100% evidence
Exact sum: 28.5 + 17.9 + 4.4 + 4 = 54.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -16.5% and the one-year return is -24.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
7Northern Trust CorporationNTRS 54.8/100Mixed-positive evidence64% evidence FADING 22.9/35 Income 15.7% · PAT 29.4% 62% evidence 12.7/25 ROA — · ROE 6% · GNPA — 34% evidence 7.1/20 P/BV 2.37× · P/BV÷ROE 0.4 70% evidence 12.1/20 RS sector 6% · RS bench 7.6% · 1Y 34.3%11 of 12 weeks ahead 100% evidence
Exact sum: 22.9 + 12.7 + 7.1 + 12.1 = 54.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8BlackRock, Inc.BLK 53.6/100Mixed-positive evidence80% evidence ASLEEP 17.2/35 Income 26.5% · PAT 2.7% 81% evidence 18.3/25 ROA 3.4% · ROE 14.9% · GNPA — 68% evidence 12.8/20 P/BV 2.31× · P/BV÷ROE 0.15 70% evidence 5.3/20 RS sector -10.4% · RS bench -9.2% · 1Y -9.2%3 of 12 weeks ahead 100% evidence
Exact sum: 17.2 + 18.3 + 12.8 + 5.3 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Affiliated Managers Group, Inc.AMG 52.3/100Mixed-positive evidence60% evidence FADING 20.2/35 Income — · PAT — 26% evidence 14.8/25 ROA 1.6% · ROE 6.1% · GNPA — 68% evidence 6.4/20 P/BV 2.94× · P/BV÷ROE 0.48 70% evidence 10.9/20 RS sector 4.4% · RS bench 5.9% · 1Y 41.2%10 of 12 weeks ahead 100% evidence
Exact sum: 20.2 + 14.8 + 6.4 + 10.9 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10StepStone Group Inc.STEP 52.3/100Thin evidence · provisional55% evidence TURNING 23.3/35 Income 69.7% · PAT — 45% evidence 13.1/25 ROA 6.9% · ROE 0.5% · GNPA — 68% evidence 9.8/20 P/BV -9.31× · P/BV÷ROE — 10% evidence 6.1/20 RS sector -18.5% · RS bench -17.7% · 1Y -25.5%3 of 12 weeks ahead 100% evidence
Exact sum: 23.3 + 13.1 + 9.8 + 6.1 = 52.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Corebridge Financial, Inc.CRBG 52.2/100Thin evidence · provisional55% evidence BREAKING OUT 19.1/35 Income 14.6% · PAT -71.3% 45% evidence 4.8/25 ROA 0% · ROE -0.5% · GNPA — 68% evidence 9.8/20 P/BV 1.01× · P/BV÷ROE — 10% evidence 18.5/20 RS sector 9.4% · RS bench 10.7% · 1Y 7%12 of 12 weeks ahead 100% evidence
Exact sum: 19.1 + 4.8 + 9.8 + 18.5 = 52.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Blackstone Inc.BX 51.3/100Mixed-positive evidence80% evidence ASLEEP 23.4/35 Income 17.2% · PAT 19.1% 81% evidence 17.2/25 ROA 5% · ROE 10.8% · GNPA — 68% evidence 4.5/20 P/BV 9.82× · P/BV÷ROE 0.91 70% evidence 6.2/20 RS sector -15.2% · RS bench -14.3% · 1Y -34.2%5 of 12 weeks ahead 100% evidence
Exact sum: 23.4 + 17.2 + 4.5 + 6.2 = 51.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15.2% and the one-year return is -34.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
13Janus Henderson Group plcJHG 51.0/100Mixed-positive evidence70% evidence 20.6/35 Income 24.5% · PAT 100% 71% evidence 11.7/25 ROA 1.2% · ROE 1.9% · GNPA — 68% evidence 5.5/20 P/BV 1.53× · P/BV÷ROE 0.81 70% evidence 13.2/20 RS sector 5.3% · RS bench 0.6% · 1Y 28.9%0 of 1 week ahead to 2026-07-02 70% evidence
Exact sum: 20.6 + 11.7 + 5.5 + 13.2 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14State Street Corporationthis pageSTT 49.7/100Mixed-negative evidence80% evidence LEADER 19.3/35 Income 12.3% · PAT 21.3% 81% evidence 8.9/25 ROA 0.3% · ROE 3.9% · GNPA — 68% evidence 6.9/20 P/BV 1.68× · P/BV÷ROE 0.43 70% evidence 14.6/20 RS sector 17.3% · RS bench 19% · 1Y 61.1%12 of 12 weeks ahead 100% evidence
Exact sum: 19.3 + 8.9 + 6.9 + 14.6 = 49.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Invesco Ltd.IVZ 48.9/100Mixed-negative evidence60% evidence BREAKING OUT 19.2/35 Income — · PAT — 26% evidence 10.8/25 ROA 1% · ROE 2.4% · GNPA — 68% evidence 7.4/20 P/BV 0.94× · P/BV÷ROE 0.39 70% evidence 11.5/20 RS sector 4.1% · RS bench 5.4% · 1Y 33.7%11 of 12 weeks ahead 100% evidence
Exact sum: 19.2 + 10.8 + 7.4 + 11.5 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Equitable Holdings, Inc.EQH 45.5/100Mixed-negative evidence76% evidence BREAKING OUT 11.8/35 Income -23.4% · PAT -126% 71% evidence 12.3/25 ROA 0.3% · ROE 24.1% · GNPA — 68% evidence 3.6/20 P/BV 38.27× · P/BV÷ROE 1.59 70% evidence 17.8/20 RS sector 9.3% · RS bench 10.6% · 1Y -0.6%12 of 12 weeks ahead 100% evidence
Exact sum: 11.8 + 12.3 + 3.6 + 17.8 = 45.5 · Decision use: Price leads the evidence: RS versus the benchmark is 10.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
17Franklin Resources, Inc.BEN 44.1/100Mixed-negative evidence60% evidence FADING 17.1/35 Income — · PAT — 26% evidence 8.6/25 ROA 0.4% · ROE 1.8% · GNPA — 68% evidence 5.7/20 P/BV 1.44× · P/BV÷ROE 0.8 70% evidence 12.7/20 RS sector 9.3% · RS bench 11% · 1Y 34%8 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 8.6 + 5.7 + 12.7 = 44.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Blue Owl Capital Inc.OWL 42.4/100Mixed-negative evidence60% evidence BREAKING OUT 19.5/35 Income — · PAT — 26% evidence 12.3/25 ROA 1.6% · ROE 1.9% · GNPA — 68% evidence 4.6/20 P/BV 2.94× · P/BV÷ROE 1.55 70% evidence 6.0/20 RS sector -22.9% · RS bench -22.3% · 1Y -46.5%7 of 12 weeks ahead 100% evidence
Exact sum: 19.5 + 12.3 + 4.6 + 6 = 42.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Raymond James Financial, Inc.RJF 41.6/100Mixed-negative evidence80% evidence FADING 15.6/35 Income 10.5% · PAT 8.1% 81% evidence 10.9/25 ROA 0.7% · ROE 4.8% · GNPA — 68% evidence 6.7/20 P/BV 2.3× · P/BV÷ROE 0.48 70% evidence 8.4/20 RS sector -5.5% · RS bench -4.3% · 1Y -5.5%9 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 10.9 + 6.7 + 8.4 = 41.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Ares Management CorporationARES 40.7/100Mixed-negative evidence80% evidence ASLEEP 21.7/35 Income 24% · PAT 32.9% 81% evidence 10.2/25 ROA 0.7% · ROE 3.6% · GNPA — 68% evidence 3.4/20 P/BV 6.38× · P/BV÷ROE 1.77 70% evidence 5.4/20 RS sector -15.3% · RS bench -14.5% · 1Y -32.1%6 of 12 weeks ahead 100% evidence
Exact sum: 21.7 + 10.2 + 3.4 + 5.4 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Blackstone Secured Lending FundBXSL 39.3/100Mixed-negative evidence62% evidence TURNING 9.5/35 Income -22.6% · PAT -19.1% 55% evidence 11.9/25 ROA — · ROE 3.4% · GNPA — 34% evidence 8.6/20 P/BV 0.9× · P/BV÷ROE 0.27 70% evidence 9.3/20 RS sector -8.3% · RS bench -7% · 1Y -10.2%0 of 12 weeks ahead 100% evidence
Exact sum: 9.5 + 11.9 + 8.6 + 9.3 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22TPG Inc.TPG 38.8/100Mixed-negative evidence64% evidence BREAKING OUT 17.1/35 Income 11.5% · PAT 100% 71% evidence 4.2/25 ROA -0.8% · ROE -3.4% · GNPA — 68% evidence 9.4/20 P/BV 5.73× · P/BV÷ROE — 10% evidence 8.1/20 RS sector -14.5% · RS bench -13.8% · 1Y -27.2%6 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 4.2 + 9.4 + 8.1 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Apollo Global Management, Inc.APO 37.8/100Mixed-negative evidence80% evidence ASLEEP 18.3/35 Income 41.2% · PAT -17.5% 81% evidence 9.4/25 ROA 0.5% · ROE 5.5% · GNPA — 68% evidence 5.8/20 P/BV 3.24× · P/BV÷ROE 0.59 70% evidence 4.3/20 RS sector -9.9% · RS bench -8.8% · 1Y -14%0 of 12 weeks ahead 100% evidence
Exact sum: 18.3 + 9.4 + 5.8 + 4.3 = 37.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24KKR & Co. Inc.KKR 34.2/100Adverse evidence80% evidence ASLEEP 17.4/35 Income 31.1% · PAT 13.5% 81% evidence 6.9/25 ROA 0.1% · ROE 1.5% · GNPA — 68% evidence 4.2/20 P/BV 2.65× · P/BV÷ROE 1.77 70% evidence 5.7/20 RS sector -17.2% · RS bench -16.4% · 1Y -35%4 of 12 weeks ahead 100% evidence
Exact sum: 17.4 + 6.9 + 4.2 + 5.7 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Blue Owl Capital CorporationOBDC 31.2/100Adverse evidence62% evidence TURNING 9.0/35 Income -11% · PAT -50.5% 55% evidence 9.9/25 ROA — · ROE 0.5% · GNPA — 34% evidence 4.8/20 P/BV 0.77× · P/BV÷ROE 1.53 70% evidence 7.5/20 RS sector -12.8% · RS bench -11.6% · 1Y -20.7%0 of 12 weeks ahead 100% evidence
Exact sum: 9 + 9.9 + 4.8 + 7.5 = 31.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Brookfield CorporationBN 26.2/100Adverse evidence80% evidence ASLEEP 12.9/35 Income 1.8% · PAT 21% 81% evidence 8.7/25 ROA 0.7% · ROE 0.4% · GNPA — 68% evidence 3.8/20 P/BV 2.24× · P/BV÷ROE 5.6 70% evidence 0.8/20 RS sector -22.7% · RS bench -21.6% · 1Y -22.6%0 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 8.7 + 3.8 + 0.8 = 26.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27The Carlyle Group Inc.CG 22.8/100Adverse evidence64% evidence ASLEEP 5.9/35 Income -28.9% · PAT -44% 71% evidence 5.9/25 ROA 0.3% · ROE -2.1% · GNPA — 68% evidence 9.6/20 P/BV 3.22× · P/BV÷ROE — 10% evidence 1.4/20 RS sector -28.5% · RS bench -27.6% · 1Y -41.3%2 of 12 weeks ahead 100% evidence
Exact sum: 5.9 + 5.9 + 9.6 + 1.4 = 22.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Pershing Square Inc.PS 57.5/100Thin evidence · provisional42% evidence BREAKING OUT 29.2/35 Income 68.8% · PAT 100% 71% evidence 8.3/25 ROA 1% · ROE -35.8% · GNPA — 68% evidence 10.0/20 P/BV — · P/BV÷ROE — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —3 of 8 weeks ahead 0% evidence
Exact sum: 29.2 + 8.3 + 10 + 10 = 57.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Ares Capital CorporationARCC 42.3/100Thin evidence · provisional46% evidence TURNING 16.5/35 Income — · PAT — 10% evidence 10.4/25 ROA — · ROE 1.2% · GNPA — 34% evidence 5.9/20 P/BV 0.96× · P/BV÷ROE 0.8 70% evidence 9.5/20 RS sector -8% · RS bench -6.7% · 1Y -10.2%1 of 12 weeks ahead 100% evidence
Exact sum: 16.5 + 10.4 + 5.9 + 9.5 = 42.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is State Street Corporation's stock price today?

State Street Corporation trades at $183, +61.1% over the past year. The company is valued at $50.0 B. The stock sits at 86% of its 52-week range of $111–$194, +20.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 72 weeks in. — as of 17 September 2026.

What were State Street Corporation's latest quarterly results?

State Street Corporation reported total income of $4.0 B and net profit of $1.1 B for the Jun 26 quarter. Income rose 17.4% and profit rose 56.5% year on year. Earnings per share were $3.65. The net margin was 26.7%, 6.7 pp higher than a year earlier. — as of 17 September 2026.

What is State Street Corporation's revenue?

State Street Corporation reported revenue of $4.0 B in the Jun 26 quarter, +17.4% year on year. For the full FY25 fiscal year, revenue was $13.9 B (+7.2%). Over the last 4 years revenue compounded at 3.8% a year. — as of 17 September 2026.

What is State Street Corporation's profit?

State Street Corporation earned $1.1 B of net profit in the Jun 26 quarter, +56.5% year on year — the 2nd straight quarter of growth. Full-year FY25 profit was $2.9 B. The net margin ran 26.7% in the latest quarter. — as of 17 September 2026.

What is State Street Corporation's market cap?

State Street Corporation's market capitalisation is $50.0 B at a stock price of $183. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.

What is State Street Corporation's P/BV ratio?

State Street Corporation trades at a P/BV of 2.0×, at the most expensive it has been in 5 years, against a long-run median of 1.1×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.

Does State Street Corporation pay a dividend?

Yes — State Street Corporation declared $0.84 per share for Jun 26, and $3.36 per share across the last four reported quarters. — as of 17 September 2026.

What is State Street Corporation's dividend per share?

State Street Corporation's most recently declared dividend is $0.84 per share for Jun 26, giving $3.36 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 17 September 2026.

What is State Street Corporation's dividend yield?

State Street Corporation's trailing dividend yield is 1.84%: $3.36 declared per share across the last four reported quarters, against a share price of $183. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 17 September 2026.

Is State Street Corporation overvalued?

On its own history, State Street Corporation looks expensive: its P/BV of 2.0× sits at the most expensive it has been in 5 years (long-run median 1.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 17 September 2026.

Is State Street Corporation growing?

Yes — State Street Corporation is growing: latest-quarter revenue +17.4% year on year, profit +56.5%, and the net margin +6.7 pp at 26.7%. The 4-year compound rates are 3.8% (revenue) and 2.2% (profit). The earnings engine currently reads: improving — as of 17 September 2026.

How is State Street Corporation performing?

State Street Corporation is in a confirmed uptrend, 72 weeks in. Its latest quarter's income rose 17.4% and profit rose 56.5% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 26 weeks. This describes what the data did, not a rating. — as of 17 September 2026.

What stage is State Street Corporation in?

Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +54.6% at its peak to +21.5% but is still expanding, ROE holding at 12.4%. The read comes from the last 12 quarters of growth (revenue growth +12.4% latest, profit growth +21.5% latest, eps growth +27.0% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.

Is State Street Corporation in an uptrend?

Yes — the price is in a confirmed uptrend (week 72 of stage 2), trading +20.7% versus its 200-day average and at 86% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.

Is State Street Corporation beating the market?

On recent form, yes — State Street Corporation has been ahead of the S&P 500 on a trailing-13-week view for 26 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +244% against the S&P 500's +255% — behind the index over the full window. — as of 17 September 2026.

Will State Street Corporation's stock price go up?

This page publishes no price forecast for State Street Corporation. What it measures instead: the stock price is $183, the price is in a confirmed uptrend 72 weeks in. Its P/BV of 2.0× sits at the 100th percentile of its own 5-year range. — as of 17 September 2026.

Is the market betting against State Street Corporation?

No — short interest is 0.0% of State Street Corporation's tradable float, about 0.0 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.

Where is State Street Corporation in its business cycle?

State Street Corporation's FY25 net margin was 21.1%, against a 5-year band of 16.2%–22.8%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 26.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.

What could break the State Street Corporation story?

The sharpest disagreement: the price moved +61.1% in a year while annual EPS moved +14.5% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.

Is State Street Corporation a stock worth studying right now?

This is not investment advice. The machine read: State Street Corporation's price has outrun its earnings. +61.1% in a year against EPS +14.5% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-17. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI